This firm fixed price purchase order from the Department of Health and Human Services (HHS) awards Biobot Analytics Inc. $1.94 million to provide COVID-19 wastewater data testing services. The contract supports HHS' Office of the Assistant Secretary for Administration under the Coronavirus COVID-19 national interest code. Per the solicitation, Biobot will collect and test samples from at least 320 wastewater treatment facilities serving over 100 million U.S. citizens across all 50 states and...
The U.S. Army Public Health Center in Aberdeen, Maryland awarded a $81,120 firm fixed price purchase order to Biobot Analytics Inc. for COVID-19 wastewater sample analysis. The contract was not set aside. Biobot Analytics is a small disadvantaged business that specializes in wastewater epidemiology data and analysis. This award is part of the Defense Health Agency's efforts to monitor COVID-19 through wastewater testing. Biobot Analytics has prior experience providing wastewater-based monitoring...
The Centers for Disease Control and Prevention (CDC) has awarded a $38,760,799.92 firm-fixed-price definitive contract to Verily Life Sciences LLC, a subsidiary of Alphabet Inc., to provide wastewater surveillance testing services. The contract, which has no set-aside designation, will support the CDC's ongoing COVID-19 and monkeypox response efforts, as well as prepare for future public health emergencies. Under the contract, Verily will establish sample collection relationships with wastewater...
This is a firm fixed price purchase order (contract) awarded by the Defense Health Agency to Biobot Analytics Inc., a self-certified small disadvantaged business, to provide SARS-COV-2 analytical services. The contract is valued at $129,600.00 and has a completion date of March 13, 2025. The original solicitation was set aside for total small business and required the contractor to provide ribonucleic acid (RNA) virus detection using quantitative polymerase chain reaction (qPCR) and reverse...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $681,553.26 firm fixed-price definitive contract to Aquavitas, LLC, a for-profit limited liability company, for genomic sequencing of wastewater samples and analysis to detect the presence of the SARS-CoV-2 virus. The contract, which does not have a set-aside designation, has a completion date of February 14, 2022 and was awarded on September 24, 2021. The place of performance is Scottsdale, Arizona....
The Centers for Disease Control and Prevention (CDC) awarded a $4.2 million definitive contract to Luminultra Technologies Inc. to provide Coronavirus (COVID-19) wastewater sampling services. The firm fixed price contract will be performed in Halethorpe, Maryland from December 21, 2021 through June 15, 2022. As a total small business set aside, Luminultra Technologies Inc. will serve as the prime contractor to support the CDC's National Interest Action efforts to monitor COVID-19 levels in...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $5.6 million firm fixed price definitive contract to Verily Life Sciences LLC for wastewater surveillance testing. Under the contract, Verily Life Sciences will monitor wastewater samples to support the CDC's disease surveillance programs. The work will be performed by Verily Life Sciences in South San Francisco, California over a six-month period concluding in May 2024. No...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a purchase order contract to Soller Environmental, LLC, a small consulting firm, for wastewater surveillance services. The $134,985 time and materials contract supports COVID-19 monitoring efforts through wastewater surveillance modeling. As a subcontractor, Soller Environmental has also provided toxicological and microbial support services to the Environmental Protection Agency's Health and Ecological...
This $23,040 firm-fixed-price purchase order was awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Biobot Analytics Inc., a self-certified small disadvantaged business. The contract is for Biobot to provide monthly COVID-19 wastewater sampling, testing, and data analysis services for the Fort Belknap Reservation in Montana. The period of performance is from September 1, 2020 through August 31, 2021. This award was made through...
The Centers for Disease Control and Prevention (CDC) awarded GT Molecular, Inc., doing business as GT Molecular LLC, a $1,665,445.00 firm-fixed-price contract to develop, optimize, and validate a portfolio of molecular testing assays for the National Wastewater Surveillance System (NWSS). This 5-year contract, with a 12-month base period and four 12-month option periods, is set aside for small businesses. GT Molecular, a minority-owned small disadvantaged business, will provide digital PCR-based...